AURKB, CHEK1 and NEK2 as the Potential Target Proteins of Scutellaria barbata on Hepatocellular Carcinoma: An Integrated Bioinformatics Analysis

被引:10
|
作者
Huang, Chaoyuan [1 ]
Luo, Hu [1 ]
Huang, Yuancheng [1 ]
Fang, Chongkai [1 ]
Zhao, Lina [2 ]
Li, Peiwu [2 ]
Zhong, Chong [3 ]
Liu, Fengbin [2 ,4 ]
机构
[1] Guangzhou Univ Chinese Med, Clin Med Sch 1, Guangzhou, Peoples R China
[2] Guangzhou Univ Chinese Med, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Peoples R China
[3] Guangzhou Univ Chinese Med, Dept Hepatobiliary Surg, Affiliated Hosp 1, Guangzhou, Peoples R China
[4] Guangzhou Univ Chinese Med, Dept Gastroenterol, Baiyun Hosp, Affiliated Hosp 1, Guangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
Scutellaria barbata; hepatocellular carcinoma; effector mechanism; network pharmacology; bioinformatics analysis; molecular docking; DIFFERENTIALLY EXPRESSED GENES; CELL-CYCLE REGULATION; KINASE; CANCER; PATHWAYS; SPINDLE;
D O I
10.2147/IJGM.S318077
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We aim to explore the potential anti-HCC mechanism of Scutellaria barbata through integrated bioinformatics analysis. Methods: We searched active ingredients and related targets of Scutellaria barbata via TCMSP database, PubChem and SwissTargetPrediction database. Then, we identified HCC disease targets from GEO dataset by WGCNA. Next, the intersected targets of disease targets and drug targets were input into STRING database to construct PPI networking in order to obtain potential therapeutic targets of Scutellaria barbata. Cytoscape software was used to carry out network topology analysis of potential targets. We used the R package for GO analysis and KEGG analysis. Finally, we used AutoDock vina and PyMOL software for molecular docking. Results: Sixteen active components from Scutellaria barbata were lastly selected for further investigation. A total of 442 component targets were identified from 16 active ingredients of Scutellaria barbata after the removal of duplicate targets. GSE45436 was selected for construction of WGCNA and screening of differentially expressed genes. A total of 354 genes were up-regulated in HCC samples and 100 were down-regulated in HCC patients. Twenty-one common genes were obtained by intersection and 10 critical targets were filtered for further investigation. The enrichment analysis showed that cell cycle, DNA replication, p53 signaling pathway were mainly involved. The molecular docking results showed that 4 potential combinations were with the best binding energy and molecular interactions. Conclusion: AURKB, CHEK1 and NEK2 could be the potential target proteins of Scutellaria barbata in treating HCC. Cell cycle, DNA replication, p53 signaling pathway consist of the fundamental regulation cores in this mechanism.
引用
收藏
页码:3295 / 3312
页数:18
相关论文
共 50 条
  • [1] Integrative Bioinformatics Analysis Identifies NEK2 as a Potential Biomarker in Head and Neck Squamous Cell Carcinoma
    Liu, Shanshan
    Tian, Wenjuan
    Li, Burong
    JOURNAL OF COMPUTATIONAL BIOLOGY, 2020, 27 (01) : 100 - 108
  • [2] Targets and Potential Mechanism of Scutellaria baicalensis in Treatment of Primary Hepatocellular Carcinoma Based on Bioinformatics Analysis
    Liu, Defu
    Wang, Zhengjun
    Zhong, Li
    Xie, Caoyu
    Huang, Xiaonan
    Zhi, Yaofeng
    Zhang, Yuzhuo
    Liang, Jiaying
    Shi, Zhenni
    Huang, Jin
    Zhang, Shuhe
    Zhang, Jin
    Ding, Fuping
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [3] Identification of Flap endonuclease 1 as a potential core gene in hepatocellular carcinoma by integrated bioinformatics analysis
    Li, Chuanfei
    Qin, Feng
    Hong, Hao
    Tang, Hui
    Jiang, Xiaoling
    Yang, Shuangyan
    Mei, Zhechuan
    Zhou, Di
    PEERJ, 2019, 7
  • [4] Integrative Bioinformatics Analysis Reveals CHEK1 and UBE2C as Luminal A Breast Cancer Subtype Biomarkers
    Yu, Daowu
    Liu, Shengwei
    Chen, Yijun
    Yang, Lumeng
    FRONTIERS IN GENETICS, 2022, 13
  • [5] THRSP identified as a potential hepatocellular carcinoma marker by integrated bioinformatics analysis and experimental validation
    Ding, Yuxi
    Liu, Xiaoling
    Yuan, Yue
    Sheng, Yunjian
    Li, Decheng
    Ojha, Suvash Chandra
    Sun, Changfeng
    Deng, Cunliang
    AGING-US, 2022, 14 (04): : 1743 - 1766
  • [6] Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons
    Andrew Best
    Katherine James
    Caroline Dalgliesh
    Elaine Hong
    Mahsa Kheirolahi-Kouhestani
    Tomaz Curk
    Yaobo Xu
    Marina Danilenko
    Rafiq Hussain
    Bernard Keavney
    Anil Wipat
    Roscoe Klinck
    Ian G. Cowell
    Ka Cheong Lee
    Caroline A. Austin
    Julian P. Venables
    Benoit Chabot
    Mauro Santibanez Koref
    Alison Tyson-Capper
    David J. Elliott
    Nature Communications, 5
  • [7] Human Tra2 proteins jointly control a CHEK1 splicing switch among alternative and constitutive target exons
    Best, Andrew
    James, Katherine
    Dalgliesh, Caroline
    Hong, Elaine
    Kheirolahi-Kouhestani, Mahsa
    Curk, Tomaz
    Xu, Yaobo
    Danilenko, Marina
    Hussain, Rafiq
    Keavney, Bernard
    Wipat, Anil
    Klinck, Roscoe
    Cowell, Ian G.
    Lee, Ka Cheong
    Austin, Caroline A.
    Venables, Julian P.
    Chabot, Benoit
    Koref, Mauro Santibanez
    Tyson-Capper, Alison
    Elliott, David J.
    NATURE COMMUNICATIONS, 2014, 5
  • [8] Identification and Analysis of Potential Key Genes Associated With Hepatocellular Carcinoma Based on Integrated Bioinformatics Methods
    Li, Zhuolin
    Lin, Yao
    Cheng, Bizhen
    Zhang, Qiaoxin
    Cai, Yingmu
    FRONTIERS IN GENETICS, 2021, 12
  • [9] Identifying potential prognosis markers in hepatocellular carcinoma via integrated bioinformatics analysis and biological experiments
    Hu, Xueting
    Zhou, Jian
    Zhang, Yan
    Zeng, Yindi
    Jie, Guitao
    Wang, Sheng
    Yang, Aixiang
    Zhang, Menghui
    FRONTIERS IN GENETICS, 2022, 13
  • [10] A novel prognostic target-gene signature and nomogram based on an integrated bioinformatics analysis in hepatocellular carcinoma
    Xu, Rui
    Wu, Qibiao
    Gong, Yuhan
    Wu, Yongzhe
    Chi, Qingjia
    Sun, Da
    BIOCELL, 2022, 46 (05) : 1261 - 1288